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Abstract
Pulmonary rehabilitation is a widely accepted therapeutic 
tool used to improve the quality of life and functional capacity of 
individuals with chronic lung disease. It is a multidisciplinary, 
comprehensive program designed to optimise autonomy and 
physical performance in patients with chronic respiratory 
impairment. There is sufficient evidence to support the use 
of pulmonary rehabilitation for a subset of patients and to 
indicate that it can improve exercise tolerance and symptoms 
of dyspnoea, as well as enhance health-related quality of life of 
patients with COPD and other respiratory conditions. According 
to projections in the Global Burden of Disease Study, COPD will 
be the fifth leading cause of disability-adjusted-life-year loss 
worldwide in 2020.
The goal of pulmonary rehabilitation is to help the individual 
achieve the highest level of independent functioning by 
improving pulmonary function, increasing exercise endurance 
and exercise work capacity, reducing dyspnoea and normalising 
blood gases. 
Locally, no pulmonary rehabilitation service as described by 
respiratory societies is offered. Therefore, this paper will look 
into the current research focusing on future recommendations 
for this service in the international setting with an aim of 
implementing this into the local health care system.
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Introduction
Rehabilitation is the restoration of individuals to the fullest 
medical, mental, emotional, social and vocational potential the 
individual is capable of. The basic premise of all rehabilitation 
is that it is possible to effect positive change under the poorest 
circumstances imaginable and that no effect of illness save for 
death is absolute.1
Pulmonary rehabilitation is defined as a program for 
people who have chronic lung disease.2 Its primary goal is to 
enable people to achieve and maintain their maximum level 
of independence and functioning. Although most pulmonary 
rehabilitation programs focus on people who have chronic 
obstructive pulmonary disease,2 people with other types of lung 
disease may benefit as well. The most successful rehabilitation 
programs are those in which services are provided by a 
physiotherapist, nurse, doctor, psychologist or social worker, 
and a dietitian working as the pulmonary rehabilitation team 
to coordinate complex medical services.3 
Optimal length of the rehabilitation phase
Despite the increasing propagation of the efficacy of 
pulmonary rehabilitation, there is no definitive proposal for 
the best training strategy2-4 with variances in the duration and 
frequency.5,6 Significant gains in exercise tolerance, dyspnoea, 
and quality of life have been observed following rehabilitation 
programs as short as 10 days7 and others as long as 18 months8 
with gains in exercise tolerance reported to be greater in 
the latter.9 Two randomised trials compared 3 months and 
18 months of low-intensity exercise training. The longer 
intervention led to 6% increase in the 6 minute walk distance, 
12% reduction in self-reported disability and faster completion 
of stair climbing and overhead tasks.10 No differences though 
were seen in pulmonary function studies between groups, after 
training. The investigators concluded that the benefits achieved 
after short-term pulmonary rehabilitation began to decay once 
the intervention was terminated, despite encouragement to 
continue participation in a home-based or community-based 
programme. On the other hand, Foy et al 11 showed that only 
male patients achieved greater gains in Chronic Respiratory 
Disease Questionnaire scores following the 18-month program 
(compared to 3 months). In fact, more favourable scores than 
those in the short-term group were reported for dyspnoea, 
fatigue, emotional function and task mastery. 
In a 2005 published prospective trial12 involving seven 
outpatient programmes, patients achieved significant gains 
in exercise tolerance (6 minute walk distance), dyspnoea and 
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health status (Medical Outcomes Study 36-item Short Form and 
quality-of-life index) after 12 weeks of pulmonary rehabilitation. 
Following an additional 12 weeks of rehabilitation, exercise 
tolerance, but not health status or dyspnoea, outcomes 
improved further, suggesting that programme duration may 
not impact all outcomes equally. Also, in support of longer term 
exercise training, 6-month outpatient pulmonary rehabilitation 
programmes composed of moderate-to-high-intensity aerobic 
and strength exercise training led to significant improvements 
in exercise performance and quality of life.13 Although this study 
did not compare the 6-month programme with a shorter one, 
the benefits gained following the 6-month training program 
persisted 18 months after the completion of rehabilitation. 
Severe COPD patients were also found to achieve greater 
improvements in treadmill endurance, incremental shuttle walk 
distance, and quality of life following a 7-week outpatient pulmonary 
rehabilitation programme compared with an identical program of 
only 4 weeks duration. However, patients who underwent the 
4-week programme were not reassessed at the 7-week time point 
to enable the direct comparison of outcomes.9
Overall, although some studies suggest that the duration 
of the pulmonary rehabilitation programme impacts exercise 
tolerance improvement, it is less clear that other outcomes such 
as health status or dyspnoea are similarly affected by programme 
duration. Randomised controlled trials have shown that short-
term pulmonary rehabilitation (4 to 12 weeks) can reduce the 
number of hospitalisations, improve quality of life, reduce 
respiratory symptoms, improve exercise tolerance, increase 
self-efficacy, and improve the ability to perform activities of 
daily living. However, only a few studies have looked at the 
benefits of long-term (12 weeks or more) supervised pulmonary 
rehabilitation (Table 1).
It has not been established to what degree the benefits 
of short-term pulmonary rehabilitation diminish over time, 
how long these benefits persist with continued supervised 
intervention, or the optimal nature of long-term pulmonary 
rehabilitation intervention. The confounding effects of multiple 
study designs including varying durations of exercise, education, 
breathing retraining, and home exercise interventions have 
hindered solid conclusions about these issues. 
Rehabilitation in the acute and chronic phase
Acute exacerbations of COPD represent a major burden 
for patients and health care systems.13,14 They are a common 
reason for hospital admissions and severely affect health-
related quality of life15 and prognosis.16 Mortality rates during 
hospitalisations are around 10%17 and during the following 
year hospitalisation may be as high as 40%. From the health 
care provider’s perspective, COPD is resource consuming18 and 
about 10% of COPD patients suffering from acute exacerbations 
account for over 70 percent of costs caused by COPD, primarily 
due to emergency visits and hospitalisations. 
Position papers of the American College of Physicians and 
American College of Chest Physicians provide recommendations 
on the management of acute exacerbations. However, 
no recommendations on how future exacerbations and 
hospitalisations could be prevented are indicated, despite 
this being one of the main goals of COPD management. One 
solution that has been adopted in clinical practice is to provide 
rehabilitative care after treatment of acute exacerbation 
including physical exercise, patient education focusing on self-
management strategies and psychosocial support. 
The rationale to offer rehabilitation in patients recently 
treated for acute exacerbation is to enhance quality of life, as 
in stable COPD patients14 and modify factors associated with 
increased risk for post-exacerbation morbidity and mortality. 
Patients with frequent exacerbations have more pronounced 
skeletal muscle weakness and a more limited six minute walking 
distance, which is in turn a risk factor for exacerbations and 
mortality. Thus, respiratory rehabilitation may have the potential 
to reduce hospital admissions by improving exercise capacity. It is 
surprising that research on the effects of respiratory rehabilitation 
in patients after acute exacerbations, is very scant. 
Randomised controlled trials evaluating the effects of 
pulmonary rehabilitation after hospitalisation for acute 
exacerbations of COPD,19 report improvements in outcome 
measures at three months after hospital discharge with significant 
improvements in walking distance (p=0.0002), health status 
scores (p=0.002), all four domains of the Chronic Respiratory 
Questionnaire (dyspnoea, p=0.003; fatigue, p=0.004; emotion, 
p=0.008; mastery of tasks, p<0.001). Therefore, this trend 
showed that early intervention with pulmonary rehabilitation 
after a hospital admission for acute exacerbations of COPD is 
safe and leads to statistically and clinically significant short-term 
improvements in exercise capacity and health status.19
Compared to rehabilitation during stable periods, the effects 
of rehabilitation tend to be larger after acute exacerbations. 
Studies looking at the acute phase are relatively small in 
sample size, therefore there is the tendency to overestimate 
the effect of an intervention compared to large trials. Also, 
methodological limitations were found and one cannot exclude 
that the estimates provided by the meta-analyses represent 
overestimations of the effect of respiratory rehabilitation after 
acute exacerbation. Therefore, larger trials seem justified to 
challenge the data available. 
When conducting studies post acute exacerbations, 
recruitment of patients may be difficult because not all of them 
may want to be randomly allocated to respiratory rehabilitation 
or conventional care, in a situation of poor health status. It 
must also be taken into consideration that exercise capacity is 
particularly low after acute exacerbations, and therefore the 
exercise programme should be designed carefully. Strength 
exercise and tolerable whole body exercise modalities such 
as interval exercise may be particularly suitable for these 
patients.19 Rehabilitation may not only reduce the number of 
acute exacerbations, but also their severity. Patients may learn 
to notice imminent exacerbations and seek medical attention 
earlier leading to a shift from inpatient to the less costly 
outpatient treatment of acute exacerbations. The significant 
reduction in hospital readmissions is suggestive of a beneficial 
cost-benefit balance. 
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Pulmonary rehabilitation in respiratory 
conditions other than COPD
Although there are some studies stretching the beneficial 
role of pulmonary rehabilitation to other respiratory diseases, 
the reported evidence is highest for COPD.19 
It is believed that pulmonary rehabilitation has positive 
effects in a large range of chronic pulmonary conditions 
including asthma.20,21 The scientific rationale for providing 
pulmonary rehabilitation to patients with non-COPD diagnoses 
is the same as for COPD. As in COPD, persons with other 
forms of chronic respiratory disease commonly experience 
deconditioning and exercise intolerance, disabling symptoms of 
dyspnoea and fatigue, impaired health status and quality of life, 
systemic inflammation, nutritional impairments, and/or muscle 
dysfunction (related to deconditioning, loss of fat-free mass, 
and/or corticosteroid use) that collectively impair functional 
status along with abnormalities of pulmonary function.20 
Modification of the relative emphasis on the core programme 
components and overall programme content may be required 
to maintain patient safety and to meet individual patient 
needs and goals which may differ from the standard goals for 
COPD.2 Disease-appropriate and age-appropriate tools for the 
assessment of exercise capacity, health status, and quality of 
life should be utilised, and efforts must be made to integrate 
topics relating to non-COPD diagnoses in situations in which the 
patient group is composed predominantly of COPD patients.
Although most of the studies published to date, which 
investigate the outcomes of pulmonary rehabilitation for 
disorders other than COPD are uncontrolled trials or case 
series, randomized clinical trials are beginning to emerge22,23 
with the strength of existing evidence supporting pulmonary 
rehabilitation varying across the different diseases.
Importance of nutritional 
and psychological care
The need of a multidisciplinary programme also includes 
nutritional and psychological assessment. Nutritional depletion 
is commonly found in COPD patients and this affects both the 
respiratory and skeletal muscle function, contributing to an 
increased morbidity and mortality.24 Schols and colleagues 
Duration of Pulmonary Rehabilitation
Study/ year Study type Country/Setting No of Patients Outcomes/results
Troosters et al. 2000 RCT: 6 vs 18 months vs usual 
care
Belgium/OP 100
Pulmonary function; exercise 
capacity; muscle strength; QOL 
Walking distance (p<0.05);exercise 
capacity (p<0.02);  no significant 
effects of training programme on PF 
measures vs usual care; improved 
quadriceps strength (p<0.05) and 
QOL (p< 0.001)
Foy et al. 2001
RCT: short- vs  
long-term
PRP
United States/OP 140
Four domains of CRQ. Significant 
changes in short vs long term in all 
domains
Green et al. 2001 RCT: single-blind; short vs long-term 
PRP
UK/OP 44
Endurance; HRQL CRDQ (p<0.011); 
dyspnoea (p<0.021), emotion 
(p<0.003), mastery (p<0.027)
Berry et al. 2003
 
RCT: single-blind; 
short vs long-term 
PRP United States/OP 140
Physical function and disability; 
pulmonary function
Disability: p<0.016 long- vs short-
term
Physical function: increased walk 
distance (p< 0.03 long term);
stair climb time (p< 0.05)
Pulmonary function: NS
Sewell et al. 2006
RCT conventional 
seven-week 
supervised program 
(n=50) or to a four-
week supervised 
programme (n=50).
100
At seven-week follow-up, patients 
in the four-week program attained 
higher submaximal exercise 
performance times for a mean 
difference 124 seconds (p=0.024).
Table 1: Reported durations and outcomes of pulmonary rehabilitation programmes.  (RCT: randomized 
clinical trial; OP: outpatient, PRP: pulmonary rehabilitation programme, QOL: quality of life; 
PF: pulmonary function; NS: not significant)
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found that patients who increased their weight by more than 
2 kg had a significantly better survival, independently of 
their initial body mass index.25 Because of the morbidity and 
mortality associated with underweight COPD patients, it is 
therefore being recommended that interventions should be 
extended to prevention and early treatment of weight loss, 
before patients become extremely wasted, and therefore put 
more emphasis on dietary change than on medically prescribed 
supplementation.2,17
The psychological input is also required as patients with 
chronic respiratory diseases have an increased risk for anxiety, 
depression, and other mental health disorders26,27 leading to 
frustration with poor health and an inability to participate 
in activities which can present as irritability, and a hostile 
attitude toward others. In the later stages of respiratory 
disease, progressive feelings of hopelessness and inability to 
cope often occur. When psychologic support is provided within 
the rehabilitation setting, one will be able to help facilitate the 
adjustment process by encouraging adaptive thoughts and 
behaviours as well as helping patients to reduce any negative 
emotions present.
As is documented in a review of randomized studies, 
Griffiths and colleagues reported reduced symptoms of anxiety 
and depression following a 6-week pulmonary rehabilitation 
program, with symptoms of depression remaining significantly 
reduced at the 12-month follow-up.28 Also, Emery and 
colleagues29 found reduced anxiety and improved cognitive 
function following a 10-week pulmonary rehabilitation 
intervention. 
Recommendations and conclusion
With a constant increase in COPD patients, and this disease 
ranking 4th for mortality and morbidity rates, more research in 
this field is required to further look into the above discussed 
issues in order to help the local development of the best 
pulmonary rehabilitation service for the treatment of respiratory 
patients. Coordination of services is very important, especially 
during episodes of exacerbation, which are characterized with 
high morbidity and a marked increase in use of health care 
resources.
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